O
Ovid Therapeutics Inc. (OVID)
NCM – Real Time Price. Currency in USD
2.55
+0.13 (5.37%)
At close: Jun 26, 2026, 4:00 PM EDT
2.55
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.55
+0.13 (5.37%)
At close: Jun 26, 2026, 4:00 PM EDT
2.55
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:37 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $94.1M significantly exceed its total debt $13.1M, ensuring strong financial flexibility
Total current assets $160.1M exceed Total current liabilities $15.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$13.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.17 | 6.05 | 10 | |
| Quick ratio | 10.17 | 5.63 | 10 | |
| Debt to Equity | 0.07 | 0.30 | 9.0 | |
| Debt to Assets | 0.06 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 392K | 566K | 7M | 7M |
| Gross Profit | 121K | -1M | -34K | 7M | 7M |
| Operating Income | -56M | -59M | -62M | -42M | -48M |
| Net Income | -54M | -52M | -26M | -17M | -24M |
| EBITDA | -54M | -58M | -61M | -42M | -48M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -99.44 | -91.67 | 1.0 |
| Next quarter | -82.77 | 28.82 | 5.5 |
| Current year | -98.15 | -110 | 1.0 |
| Next year | 39.53 | -10.42 | 5.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -275.78 | -299.99 | -33.53 | 1.0 |
| Y/Y | -99.99 | -65.97 | 14.29 | -35.19 | 2.8 |
| 3y average | 383.95 | 29 | 30.58 | 9.38 | 9.0 |
| 5y average | 520.83 | 37.94 | 34.92 | 41.9 | 10 |
| Weighted average score | 5.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |